Company intelligence / Profile preview

Neurabody

Ownership: Private
Development stage: Commercial

Overview

Neurabody offers a commercialized digital health solution that uses wearable sensors and an AI-driven analytics platform to monitor posture in real time. The system provides personalized feedback, corrective exercises, ergonomic recommendations, and gamified rewards. It integrates with corporate wellness programs to reduce musculoskeletal-related absenteeism and healthcare costs. No clinical trial data reported; results are based on user engagement metrics and reported improvements in workplace productivity and well-being.

Therapeutic areas: Rheumatology
Modalities: DeviceDigital health platformAI/ML-based intervention systemWearable sensor technology
Industry: Physiological Monitoring

Beyond the preview

Go deeper on Neurabody.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurabody.

Explore the full profile